December 24, 2024 05:55 pm (IST)
NATCO receives final approval for Generic Bendamustine HCl Powder for USA Market
Jan 06, 2017, at 09:47 pm
New Delhi, Jan 6 (IBNS):Natco Pharma Limited on Friday announced the final approval of Abbreviated New Drug Application (ANDA) containing a paragraph IV certification filed with the U.S. Food and Drug Administration (FDA) for generic version of Bendamustine Hydrochloride powder for Injection, 25 mg/Vial and 100 mg/Vial (Singe-Dose Vial).
Latest Headlines